| Year |
Description |
| 2016 |
Passed the first European Directorate for the Quality of Medicine & HealthCare (EDQM) site inspection in Taiwan
|
| 2015 |
ScinoPharm (Changshu) Pharmaceutical Ltd.passed U.S. FDA inspection
|
| 2015 |
Passed the fifth U.S. FDA site inspection in Taiwan
|
| 2014 |
ScinoPharm (Changshu) Pharmaceutical Ltd.passed Mexican healthy authority(COFEPRIS) inspection |
| 2013 |
Passed the first European Medicine Agency (EMA) site inspection in Taiwan |
| 2012 |
Passed the fourth U.S. FDA site inspection in Taiwan Added to Morgan Stanley Capital International Taiwan Index, the first biotech company in Taiwan elected |
| 2011 |
Successfully completed IPO in Taiwan on September 29 (Traded on the TSEC, Company Code 1789) |
| 2010 |
Strategic investment in Tanvex Biologics, Inc., a United States company specializing in the development of biosimilars Listed on the Emerging Stock Market in Taiwan |
| 2009 |
ScinoPharm (Changshu) Pharmaceutical Ltd. Established in China Received Industrial Technology Advancement Award from the Ministry of Economic Affairs |
| 2008 |
Passed Japanese PMDA, Korean FDA & Hungarian NIP site inspections in Taiwan Passed the third U.S. FDA site inspection in Taiwan |
| 2007 |
10-year anniversary Passed Australian TGA site inspection in Taiwan |
| 2006 |
Worldwide customers and DMF registrations exceed 1000 |
| 2005 |
First NCE API supplied for commercial launch in Europe Growing product offerings including Oncology APIs, supplied to customers in Europe and South America Passed the second U.S. FDA site inspection in Taiwan Awarded the 2005 Entrepreneurial Company Award by Frost & Sullivan |
| 2004 |
First dedicated facility for early clinical material completed |
| 2003 |
First generic API supplied for commercial launch in the U.S. |
| 2002 |
Two of the three large-scale production bays validated for cGMP operations |
| 2001 |
Passed the first U.S. FDA site inspection at Taiwan manufacturing site ScinoPharm Kunshan in China and ScinoPharm Biotech established |
| 2000 |
cGMP production began in small-scale units |
| 1999 |
Relocated temporary labs and offices to present site |
| 1998 |
U.S. GMP plant construction began in the Tainan Science-Based Industrial Park |
| 1997 |
ScinoPharm Taiwan, Ltd. established |
